Localized Breast Cancer
5
1
1
2
Key Insights
Highlights
Success Rate
67% trial completion
Treatment Research
5 treatments under study, led by Peroperative Radiotherapy Technique By Papillon Tm
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
20.0%
1 terminated out of 5 trials
66.7%
-19.9% vs benchmark
0%
0 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (5)
"Mon Parcours de Vie" Localized Breast Cancer: Announcement, Support, Information on the Disease and Treatments. Pilot Study to Assess the Value of Written Information Documents.
Technique of Per-Operative Radiotherapy (RPO) by Papillon +TM in Localized Breast Cancer
Evaluation and Modeling of the Effect of G-CSF on the Evolution of Polynuclear Neutrophils During Dense Dose Epirubicin-Cyclophosphamide Regeneration
Per-Operative Radiotherapy by Papillon +TM in Localized Breast Cancer
Use of Organic Germanium or Placebo for the Prevention of Radiation Induced Fatigue
Research Network
Common Treatments
- Peroperative Radiotherapy Technique By Papillon Tm1
- Dense Dose Epirubicincyclophosphamide Chemotherapy With Administration Of Peggcsf Pegfilgrastim1
- Dense Dose Epirubicincyclophosphamide Chemotherapy And Gcsf Filgrastim Lenograstim1
- Organic Germanium1
- Papillon Tm1
Active Sponsors
- Centre Antoine Lacassagne2
- Arizona Oncology Services1
- Centre Georges Francois Leclerc1
- Institut de Cancérologie de Lorraine1
Top Investigators
Centre Antoine Lacassagne
Arizona Oncology Services
Related Conditions
- Localized Prostate Cancer1
- Patients Receiving External Beam Radiotherapy1